The Democratic Socialist and the retired Rear Admiral: How Democrats aim to win in Colorado
US Top News and Analysisby Joanna Ossinger28 Aug 2026
DENVER — The future of the Democratic Party is on display in Colorado. The state's choices for U.S.
US Top News and Analysis
cnbc.comadded August 2026
top 81%U.S. Navy blockade slashes Iran oil exports as Trump administration shifts to economic warfare
US Top News and Analysisby Spencer Kimball28 Aug 2026
Iranian crude oil exports have plunged in August as the U.S. relies on economic pressure through its naval blockade, rather than military strikes, to coerce Tehran into a deal to fully reopen the...
BioCryst is profitable. Now it wants to buy more rare disease drugs
US Top News and Analysisby Brad Quick28 Aug 2026
CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance research, innovation and patient care in rare diseases.
How Taylor Farms became integral to America's food supply system
US Top News and Analysisby Brandon Gomez28 Aug 2026
The cyclospora outbreak that has sickened thousands of people across the U.S. has brought fresh scrutiny of the integral role Taylor Farms and other massive suppliers play in the country's food...
Marc Benioff is getting his mojo back as Salesforce's AI strength quiets skeptics
US Top News and Analysisby Jordan Novet28 Aug 2026
For the better part of a year, Salesforce CEO Marc Benioff has been hearing that his company could get wiped out by AI. He's scoffed anytime someone has asked him about it.
Imax says it's open to a sale. Why is no one buying?
US Top News and Analysisby Sarah Whitten28 Aug 2026
In December, Imax CEO Rich Gelfond opened the door to a sale. Almost nine months later, the company's stock has hit an all-time high, its box office is breaking records and the stage is set to...
Labor Department to propose expansion of association health plans, which could lower insurance costs for some workers
US Top News and Analysisby Sarah Agostino28 Aug 2026
How some workers are able to access health insurance — and how much they pay for it — could be headed for a change. The U.S.
Marvell shares tumble 8% as outlook underwhelms despite 37% revenue growth
US Top News and Analysisby Sawdah Bhaimiya28 Aug 2026
Marvell Technology shares fell 8% in premarket trading despite a second-quarter revenue beat, as its raised fiscal 2028 outlook failed to meet investors' elevated expectations.
Russian forces intensify attacks in Donetsk as Ukraine lauds fresh EU push to unlock frozen assets
US Top News and Analysisby Sam Meredith28 Aug 2026
Russian forces have intensified attacks within Ukraine's so-called "fortress belt" of industrial cities in the eastern Donetsk region, seeking to ramp up pressure on critical Ukrainian strongholds...
Trump’s Greenland fixation puts security at the heart of Iceland’s knife-edge EU vote
US Top News and Analysisby Sam Meredith28 Aug 2026
Icelanders on Saturday will vote in a knife-edge referendum on whether to resume negotiations to join the European Union, reopening a debate that has taken on deeper significance in the wake of...
Six months into the Iran war: Markets become accustomed to stalemate with no end in sight
US Top News and Analysisby Chloe Taylor28 Aug 2026
Friday marks six months since the U.S. and Israel launched "major combat operations" in Iran, prompting retaliatory strikes on targets across the Gulf and sparking a new war in the Middle East.
CrowdStrike CEO: AI exposes dangerous cyber gaps that legacy tools can’t handle
US Top News and Analysisby Alexa LoMonaco27 Aug 2026
CrowdStrike CEO George Kurtz said Thursday that the rapid rise of artificial intelligence is exposing gaps in corporate cybersecurity defenses and making older security tools increasingly...
Jim Cramer says Nvidia and Salesforce earnings upended two bear narratives
US Top News and Analysisby Alexa LoMonaco27 Aug 2026
CNBC's Jim Cramer on Thursday said strong earnings results from Nvidia and Salesforce shattered two of Wall Street's biggest tech bear narratives, sending both stocks soaring.
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
US Top News and Analysisby Annika Kim Constantino27 Aug 2026
The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday.
Gap shares jump 9% after company names new Old Navy CEO to revive struggling brand
US Top News and Analysisby Laya Neelakandan27 Aug 2026
Gap on Thursday announced a new CEO for its Old Navy banner, effective Nov. 2, as the retailer tries to reinvigorate sluggish sales performance at the brand.
AI bursts to the front of Massachusetts Democratic Senate primary
US Top News and Analysisby Garrett Downs27 Aug 2026
Artificial intelligence has rocketed to the front of next Tuesday's Massachusetts Senate Democratic primary, as Rep. Seth Moulton tries to unseat Bay State political titan Sen. Ed Markey.
What Warsh will say and how the market will react, according to prediction markets
US Top News and Analysisby Ananya Chetia27 Aug 2026
Market watchers are closely listening to how elaborate Federal Reserve Chairman Kevin Warsh will be about the central bank's next decision in September and whether he'd acknowledge the U.S.
Donald Trump Jr. told Republican state attorneys not to fight prediction markets, NY Times reports
US Top News and Analysisby Davis Giangiulio; Ananya Chetia27 Aug 2026
In March, Donald Trump Jr. told Republican state attorneys general not to go after prediction markets, The New York Times reported on Thursday.
Brian Sullivan: Gulf nations are unlikely to agree to a toll plan for Strait of Hormuz safe passage
US Top News and Analysisby Brian Sullivan27 Aug 2026
What I'm hearing from energy insiders The Great Hormuz Debate. Exactly how many ships - and how much oil - are getting through the Strait of Hormuz?
Texas Senate hopeful James Talarico teams with Mark Cuban on plan to break up healthcare
US Top News and Analysisby Justin Papp27 Aug 2026
Texas Democratic Senate candidate James Talarico is out with a new plan, first shared with CNBC, to break up what he says are healthcare monopolies and bring down the cost of prescription drugs.